Volume : 10, Issue : 09, September – 2023
Title:
17.PHYTOCHEMICAL SCREENING AND PHARMACOLOGICAL EVALUATION OF ANTICANCER ACTIVITY OF METHANOLIC EXTRACT OF MAYTENUS EMARGINATA (WILLD) IN RATS
Authors :
VURIMETLA SHRUTHI*, DR.D.SWATHI,DR.NAGASREE,DR.Y.SIRISHA
Abstract :
Cancer is one of the most serious health problems that affect the duration and quality of the individual’s life. Enormous efforts are invested to cope with this problem, but unfortunately limited success has ever been achieved with most of the therapeutic strategies. These efforts are usually complicated with the need for well experienced surgeons, lack of specificity and high cost, as well as being usually accompanied with a wide range of side effects.
As the conventional therapeutic strategies fail to fulfill the major requirements for a successful cancer therapy, the use of naturally developed anticancer agents has evolved as an alternative safe, low-cost and convenient one. Therefore, the use of plant extracts with potential anticancer therapeutic effects might be particularly significant, especially in Palestine, which is rich in thousands of plant species known for their medical uses. Moreover, the lack of expertise, the scares economical resources and the complicated political situation in Palestine don’t allow the application of sophisticated surgical, chemo- and radio-therapies to cure cancer.
Therefore, the current study, investigates the effect of crude methanolic extracts from Maytenus emarginata, Fig on cell lines derived from different human tissue origins (Hep3b: Hepatocellular carcinoma; Hela: cervical epithelial cancer; and A549: human lung adrenal cancer).
The results showed a concentration-dependent reduction in the final number of cancer cells in consequence to treatment with the aforementioned methanolic extracts. Two kinds of anticancer effects were evaluated and found tocontribute to this reduction: the antiproliferation effect (decreased number of metabolically active cells) and cytotoxicity (decreased number of live cells).
This extracts possess both of the effects with various degrees. Maytenus emarginata possess the strongest and most profound effects on the three cell lines, mainly by induction of cell death.
Further studies are needed to assess the active ingredients of Maytenus emarginata, involved in the antiproliferative or cytotoxic effects of these plants. These studies must involve the establishment of in vivo animal models and the application of more efficient extraction and fractionation techniques.
Cite This Article:
Please cite this article in press Vurimetla Shruthi et al, Phytochemical Screening And Pharmacological Evaluation Of Anticancer Activity Of Methanolic Extract Of Maytenus Emarginata (Willd) In Rats, Indo Am. J. P. Sci, 2023; 10 (09).
Number of Downloads : 10
References:
1. Ballabh B and Chaurasia OP (2007). Traditional medicinal plants of cold desert Ladakh-used in treatment of cold, cough and fever. Journal of Ethnopharmacology 112:341-349.
2. Kamboj VP (2000). Herbal medicine. Current Science 78:35-38.
3. Kumar S, Shukla YN, Lavania UC, Sharma A and Singh AK (1997). Medicinal and aromatic plants: prospects for India. Journal of Medicinal and Aromatic Plant Sciences 19:361-365.
4. Ganzinger K (1982). Zur Geschichte der Termini Pharmakognosie und Pharmakodynamik. Scientia Pharmaceutica 50:351-354.
5. Betz JM, Brown PN and Roman MC (2011). Accuracy, precision, and reliability of chemical measurements in natural products research. Fitoterapia 82:44-52.
6. Ozarkar KR (2005). Studies on anti-inflammatory effects of two herbs Cissusquadrangularis Linn. and Maytenus emarginata using mouse model. Ph. D. Thesis, University of Mumbai, Mumbai.
7. Abere TA, Onwukaeme DN and Eboka CJ (2007). Pharmacognostic evaluation of leaves of Mitracarpus scaber Zucc (Rubiaceae). Tropical Journal of Pharmaceutical Research 6:849-853.
8. Bapodara M, Nagani K and Chanda S (2011). Pharmacognostic and physicochemical study of Punica granatum L. leaf. Pharmacognosy Journal 3:29-32.
9. Mukherjee PK (2002). Quality Control of Herbal Drugs, 1st (Ed.), Business Horizons Pharmaceutical Publishers, New Delhi, 131-219.
10. Joshi K, Chavan P, Warude D and Patwardhan B (2004). Moleucular markers in herbal drug technology. Current Science 87:159-165.
11. Chanda S, Nagani K and Parekh J (2010). Assessment of quality of Manilkara hexandra (Roxb.) Dubard leaf (Sapotaceae): Pharmacognostical and Physicochemical profile. Pharmacognosy Journal 2:520-524.
12. Dineshkumar C (2007). Pharmacognosy can help minimize accidental misuse of herbal medicine. Current Science 93:1356-1358.
13. World Health Organization. 2006- Fact sheet, 297.
14. Ministry of Health., 2005 – Health Status in Palestine Ministry of Health Annual Report – 2004. Palestine Health Information Center,
15. American Cancer Society. 2006 – Cancer Facts and Figures. American Cancer Society Inc, GA, U.S.A.
16. Cancer Research UK (January 2007). “UK cancer incidence statistics by age”. http://info.cancerresearchuk.org/cancerstats/incidence/age/. Retrieved on 2007-06-25.
17. Pharmacology by H. P. Rang, M. M. Dale, J. M. Ritter and P. K. Moore 7th, 255-269.
18. Bertram JS (2001). The molecular biology of cancer. Molecular Aspects of Medicine 21:167-223.
19. Amin A and Mousa M (2007). Merits of anti-cancer plants from the Arabian Gulf region. Cancer Therapy 5:55-66.
20. Bieche I (2004). Molecular biology and cancer. Immuno-analyse and Biologie Specialise 19:13-22.